EA201492081A1 - (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела - Google Patents
(r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифурателаInfo
- Publication number
- EA201492081A1 EA201492081A1 EA201492081A EA201492081A EA201492081A1 EA 201492081 A1 EA201492081 A1 EA 201492081A1 EA 201492081 A EA201492081 A EA 201492081A EA 201492081 A EA201492081 A EA 201492081A EA 201492081 A1 EA201492081 A1 EA 201492081A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- nifural
- nifuratel
- infections
- synthesis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/02—Preparation of hydrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
В заявленном изобретении раскрыт (R)-нифурател, а также его применение в качестве бактерицидного и бактериостатического агента, а также фармацевтические композиции с его содержанием; неожиданным результатом явился тот факт, что (R)-нифурател имеет лучший противомикробный профиль, чем нифурател рацемат или (S)-нифурател. Также заявлен новый процесс синтеза (R)-нифуратела и (S)-нифуратела.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20120167640 EP2662371A1 (en) | 2012-05-11 | 2012-05-11 | (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel |
| PCT/EP2013/055078 WO2013167295A1 (en) | 2012-05-11 | 2013-03-13 | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201492081A1 true EA201492081A1 (ru) | 2015-06-30 |
Family
ID=47846051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201492081A EA201492081A1 (ru) | 2012-05-11 | 2013-03-13 | (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US9284306B2 (ru) |
| EP (2) | EP2662371A1 (ru) |
| JP (1) | JP2015515998A (ru) |
| KR (1) | KR20150008871A (ru) |
| CN (1) | CN104379580A (ru) |
| AU (1) | AU2013258385A1 (ru) |
| BR (1) | BR112014027953A2 (ru) |
| CA (1) | CA2869827A1 (ru) |
| CL (1) | CL2014002951A1 (ru) |
| CO (1) | CO7131368A2 (ru) |
| CR (1) | CR20140505A (ru) |
| DO (1) | DOP2014000252A (ru) |
| EA (1) | EA201492081A1 (ru) |
| EC (1) | ECSP14026432A (ru) |
| GE (2) | GEP201606595B (ru) |
| HK (1) | HK1202539A1 (ru) |
| IL (1) | IL235429A0 (ru) |
| IN (1) | IN2014DN09256A (ru) |
| MA (1) | MA20150279A1 (ru) |
| MX (1) | MX2014013759A (ru) |
| NZ (1) | NZ700752A (ru) |
| PE (1) | PE20150167A1 (ru) |
| PH (2) | PH12014502500A1 (ru) |
| SG (2) | SG11201406447SA (ru) |
| TN (1) | TN2014000430A1 (ru) |
| WO (1) | WO2013167295A1 (ru) |
| ZA (1) | ZA201407596B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108254453A (zh) * | 2016-12-28 | 2018-07-06 | 苏州电器科学研究院股份有限公司 | 一种有效测定塑料制品中邻苯二甲酸酯含量的检测方法 |
| RU2020113749A (ru) | 2017-09-20 | 2021-10-20 | пиЭйч ФАРМА Ко., ЛТД. | Аналоги таиланстатина |
| CN108760950B (zh) * | 2018-04-25 | 2022-07-15 | 国检测试控股集团京诚检测有限公司 | 一种测定硝基呋喃代谢物的方法 |
| CN111892557B (zh) * | 2019-05-05 | 2022-11-08 | 河北圣泰材料股份有限公司 | 哌嗪类成膜离子液体的合成方法 |
| CN110672765B (zh) * | 2019-10-11 | 2022-03-18 | 温州海鹤药业有限公司 | 一种定量检测硝呋太尔中顺式异构体杂质的方法 |
| CN112457304B (zh) * | 2020-12-07 | 2022-03-11 | 中国药科大学 | 一种硝呋太尔的制备方法 |
| CN113828243B (zh) * | 2021-09-14 | 2022-06-28 | 南京南大药业有限责任公司 | 一种硝呋太尔制霉菌素栓制造方法及设备 |
| WO2024220546A2 (en) | 2023-04-17 | 2024-10-24 | Peak Bio, Inc. | Antibodies and antibody-drug conjugates and methods of use and synthetic processes and intermediates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE635608A (ru) | 1962-08-01 | |||
| CN100506820C (zh) | 2006-03-16 | 2009-07-01 | 韩志强 | (s)-硝呋太尔,其制备方法和应用 |
| CN100516063C (zh) * | 2006-03-16 | 2009-07-22 | 韩志强 | 硝呋太尔的生产方法 |
| CN101434584A (zh) * | 2007-11-15 | 2009-05-20 | 中山大学 | 具有抗菌活性的手性噁唑烷酮类化合物 |
| EP2243482A1 (en) * | 2009-04-20 | 2010-10-27 | Polichem SA | Use of nifuratel to treat infections caused by atopobium species |
-
2012
- 2012-05-11 EP EP20120167640 patent/EP2662371A1/en not_active Withdrawn
-
2013
- 2013-03-13 CN CN201380022803.0A patent/CN104379580A/zh active Pending
- 2013-03-13 KR KR20147031517A patent/KR20150008871A/ko not_active Application Discontinuation
- 2013-03-13 NZ NZ700752A patent/NZ700752A/en not_active IP Right Cessation
- 2013-03-13 CA CA 2869827 patent/CA2869827A1/en not_active Abandoned
- 2013-03-13 US US14/400,071 patent/US9284306B2/en not_active Expired - Fee Related
- 2013-03-13 MA MA37496A patent/MA20150279A1/fr unknown
- 2013-03-13 BR BR112014027953A patent/BR112014027953A2/pt not_active IP Right Cessation
- 2013-03-13 AU AU2013258385A patent/AU2013258385A1/en not_active Abandoned
- 2013-03-13 IN IN9256DEN2014 patent/IN2014DN09256A/en unknown
- 2013-03-13 JP JP2015510685A patent/JP2015515998A/ja active Pending
- 2013-03-13 MX MX2014013759A patent/MX2014013759A/es unknown
- 2013-03-13 GE GEAP201313660A patent/GEP201606595B/en unknown
- 2013-03-13 EP EP13708840.7A patent/EP2847189A1/en not_active Withdrawn
- 2013-03-13 PE PE2014001944A patent/PE20150167A1/es not_active Application Discontinuation
- 2013-03-13 WO PCT/EP2013/055078 patent/WO2013167295A1/en active Application Filing
- 2013-03-13 GE GEAP201313967A patent/GEP201706626B/en unknown
- 2013-03-13 SG SG11201406447SA patent/SG11201406447SA/en unknown
- 2013-03-13 EA EA201492081A patent/EA201492081A1/ru unknown
- 2013-03-13 SG SG10201608485XA patent/SG10201608485XA/en unknown
-
2014
- 2014-10-16 TN TN2014000430A patent/TN2014000430A1/fr unknown
- 2014-10-20 ZA ZA2014/07596A patent/ZA201407596B/en unknown
- 2014-10-30 IL IL235429A patent/IL235429A0/en unknown
- 2014-10-30 CL CL2014002951A patent/CL2014002951A1/es unknown
- 2014-11-03 CR CR20140505A patent/CR20140505A/es unknown
- 2014-11-07 DO DO2014000252A patent/DOP2014000252A/es unknown
- 2014-11-10 PH PH12014502500A patent/PH12014502500A1/en unknown
- 2014-11-11 EC ECIEPI201426432A patent/ECSP14026432A/es unknown
- 2014-11-11 CO CO14248543A patent/CO7131368A2/es unknown
-
2015
- 2015-01-28 US US14/607,464 patent/US9067927B2/en not_active Expired - Fee Related
- 2015-03-26 HK HK15103057.7A patent/HK1202539A1/xx unknown
- 2015-09-24 PH PH12015502241A patent/PH12015502241A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201492081A1 (ru) | (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201400838A1 (ru) | ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ | |
| DOP2016000253A (es) | Nuevos compuestos | |
| GEP201606598B (en) | Heteroaromatic compounds as dopamine d1 ligands | |
| EA201591618A1 (ru) | Замещенные имидазопиридазины | |
| EA201892822A1 (ru) | Новые антибактериальные соединения | |
| GEP201706725B (en) | Compounds and compositions as inhibitors of mek | |
| EA201490688A1 (ru) | 2-тиопиримидиноны | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
| EA201791174A1 (ru) | Антимикотическое соединение | |
| EA201690183A1 (ru) | Замещенные пиразолопиридинамины | |
| EA201690783A1 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
| EA201501187A1 (ru) | Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний | |
| EA201790070A1 (ru) | Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70 | |
| EA201591180A1 (ru) | Составы ингибитора lfa-1 | |
| EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
| DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
| EA201890419A1 (ru) | ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ |